Patient characteristics and transduction efficiency
Patient no. . | FAB type . | Cytogenetics . | %LNGFr+ . | |
---|---|---|---|---|
LXLN . | IL-7LN . | |||
1 | M1 | inv.3 | 26 | 16 |
2 | M5a | t(9:11) | 17 | 10 |
3 | M5b | 46XX | 20 | 16 |
4 | M5b | 46XY | 35 | 30 |
5 | M5b | 46XY | 26 | 21 |
6 | M2 | 46XY | 12 | 9 |
7 | M2 | ND | 16 | 7 |
8 | M4 | 46XY | 6 | 5 |
Patient no. . | FAB type . | Cytogenetics . | %LNGFr+ . | |
---|---|---|---|---|
LXLN . | IL-7LN . | |||
1 | M1 | inv.3 | 26 | 16 |
2 | M5a | t(9:11) | 17 | 10 |
3 | M5b | 46XX | 20 | 16 |
4 | M5b | 46XY | 35 | 30 |
5 | M5b | 46XY | 26 | 21 |
6 | M2 | 46XY | 12 | 9 |
7 | M2 | ND | 16 | 7 |
8 | M4 | 46XY | 6 | 5 |
Leukemic blast were cultured in serum-free medium with SCF, GM-CSF, FL, IL-3, and TNFalpha for 48 hours before 3 rounds of infection with viral supernatants containing either the IL-7 cytokine (IL-7LN) or the reporter gene alone (LXLN). Transduction efficiency was monitored by flow cytometry using specific LNGFr mAb, 48 to 72 hours after the last transduction (n = 8, mean ± SD). Mean % LNGFr+ values (± SDs) were 19.8 ± 9 for LXLN and 12.7 ± 8.3 for IL-7LN.
FAB indicates French-American-British; ND, not done.